Why are narcotics avoided before and during a HIDA (hepatobiliary iminodiacetic acid) scan?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Why Narcotics Are Avoided Before and During HIDA Scans

Opioid narcotics must be withheld for at least 48 hours before HIDA scanning because they cause spasm of the sphincter of Oddi and impair gallbladder contraction, leading to false-positive results that can mimic bile duct obstruction or falsely decrease gallbladder ejection fraction. 1, 2

Mechanism of Interference

Opioids directly cause biliary sphincter spasm, which has two critical effects on HIDA scan interpretation:

  • They markedly delay clearance of the radiotracer (Tc-99m HIDA) from the common bile duct, simulating common bile duct obstruction in otherwise healthy individuals 3
  • They spuriously decrease gallbladder ejection fraction (GBEF) by acting on the sphincter of Oddi and reducing gallbladder contractility, even though the gallbladder itself may be functioning normally 4
  • Opioid metabolites circulate in the blood for many hours and continue to affect biliary sphincter function long after administration 4

Clinical Consequences of Opioid Use

The interference from narcotics can lead to serious diagnostic errors:

  • False-positive diagnosis of bile duct obstruction when delayed radiotracer clearance is misinterpreted as anatomical obstruction, potentially leading to unnecessary common bile duct exploration 3
  • False-positive diagnosis of chronic cholecystitis or biliary dyskinesia when a low ejection fraction (<38%) is actually caused by opioid-induced sphincter dysfunction rather than true gallbladder disease 1, 4
  • Nonvisualization of the gallbladder may occur due to functional obstruction at the sphincter of Oddi rather than true cystic duct obstruction 4

Specific Medication Restrictions

The following drugs must be avoided before HIDA scanning:

  • Opiates: withhold for at least 48 hours (includes morphine, meperidine, hydromorphone, oxycodone, hydrocodone, fentanyl, and all other opioid analgesics) 1, 2, 3
  • Anticholinergic drugs: withhold for at least 48 hours because they directly impair gallbladder contraction 1
  • Other medications to avoid within 24 hours: nifedipine, indomethacin, octreotide, theophylline, benzodiazepines, phentolamine, isoproterenol, and progesterone 1
  • Nicotine and alcohol should also be avoided prior to testing 1

Critical Pitfalls to Avoid

Taking a careful drug history is essential before interpreting any HIDA scan with abnormal findings, especially when evaluating for:

  • Chronic acalculous cholecystitis or biliary dyskinesia (where GBEF is the primary diagnostic criterion) 4
  • Suspected bile duct obstruction (where delayed clearance is the key finding) 3

If a patient has received opioids within 48 hours of the scan, the study should ideally be rescheduled rather than proceeding with interpretation that may be unreliable 1, 2. If clinical urgency prevents rescheduling, the interpreting physician must be informed of recent opioid use so results can be interpreted with appropriate caution 4.

Additional Patient Preparation Requirements

Beyond medication restrictions, proper HIDA scan preparation includes:

  • Fasting for at least 4-6 hours (optimally overnight) to ensure adequate gallbladder filling and avoid false-positive results 1, 2
  • Performing the study on an outpatient basis when possible, not during acute illness, to avoid confounding factors 1, 2
  • Avoiding the study in patients taking chronic opioid therapy unless they can safely discontinue for 48 hours, as chronic use may cause persistent sphincter dysfunction 4

References

Guideline

Diagnostic Approach for Gallstone Cholecystitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

HIDA Scan Protocol for Acute Cholecystitis and Functional Gallbladder Disorder

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

How long should a patient hold opiates (opioid analgesics) before a Hida scan and do they need to be NPO (nothing by mouth)?
Can a patient take pain medications, such as opioids (narcotics) or acetaminophen (Tylenol), before undergoing a Hepatobiliary Iminodiacetic Acid (HIDA) scan?
Can I administer Ofirmev (acetaminophen) to a patient with pending Hepatobiliary Iminodiacetic Acid (HIDA) scan for pain management?
Can a HIDA (Hepatobiliary Iminodiacetic Acid) scan be performed with intravenous (IV) glucose running?
Does Cholecystokinin (CCK) cause voiding during medical imaging procedures?
Three weeks after a miscarriage, my quantitative beta‑human chorionic gonadotropin (hCG) is 6.2 IU/L, I have light brown‑red spotting, and endometrial thickness is 8 mm— is this normal and how should I be managed?
In a multiparous adult woman with six prior cesarean sections who requests a seventh cesarean and is offered tubal ligation, should consent be obtained from (A) the patient (or her legal representative), (B) both patient and husband, (C) the patient with instruction to inform her husband, or (D) an ethics committee?
What are the typical presentation, laboratory findings, and acute management of hyperosmolar hyperglycemic state in an older adult with type 2 diabetes?
Does prazosin worsen amlodipine‑induced peripheral edema?
What is the recommended management for acute bronchitis and chronic bronchitis (including COPD), covering supportive measures, antitussives, NSAIDs, bronchodilators, corticosteroids, and indications for antibiotics?
Does concomitant use of two antibiotics increase the risk of kidney injury?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.